-
Founded in:
1994-12-05 -
Country:
China -
Address:
No. 50, Majia Street, Gulou District, Nanjing -
Tax NO.:
91320000134755425F -
Registered Funds:
98 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| POLYETHYLENE GLYCOL MONO-4-NONYLPHENYL ETHER |
Pharmacological action not specified
More
Pharmacological action not specified |
26027-38-3 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Magnesium salicylate |
Not clearly described
More
Not clearly described |
18917-89-0 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Magnesium salicylate |
This product is a non-steroidal antipyretic analgesic with antipyretic, analgesic and anti-inflammatory effects. It has almost no effect on platelet aggregation.
More
This product is a non-steroidal antipyretic analgesic with antipyretic, analgesic and anti-inflammatory effects. It has almost no effect on platelet aggregation. |
545mg | 18917-89-0 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Meloxicam |
Meloxicam is a nonsteroidal anti-inflammatory analgesic (NSAID) of the enolic acid class, which has anti-inflammatory, analgesic and antipyretic effects. It exerts its pharmacological effects by inhibiting the biosynthesis of inflammatory mediators prostaglandins, and its selective inhibition of COX-2 is more potent than that of COX-1, thereby reducing the incidence of gastrointestinal and renal side effects.
More
Meloxicam is a nonsteroidal anti-inflammatory analgesic (NSAID) of the enolic acid class, which has anti-inflammatory, analgesic and antipyretic effects. It exerts its pharmacological effects by inhibiting the biosynthesis of inflammatory mediators prostaglandins, and its selective inhibition of COX-2 is more potent than that of COX-1, thereby reducing the incidence of gastrointestinal and renal side effects. |
71125-38-7 | 57 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tranilast |
It stabilizes the cell membranes of mast cells and basophils, preventing their degranulation, thereby inhibiting the release of histamine and 5-hydroxytryptamine allergic reaction substances. It has a significant inhibitory effect on skin allergic reactions and experimental asthma in rats caused by 1gE antibodies.
More
It stabilizes the cell membranes of mast cells and basophils, preventing their degranulation, thereby inhibiting the release of histamine and 5-hydroxytryptamine allergic reaction substances. It has a significant inhibitory effect on skin allergic reactions and experimental asthma in rats caused by 1gE antibodies. |
53902-12-8 | 2 |